Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs Imipenem in Complicated Intra-Abdominal Infection or Ventilator-Associated Pneumonia
2007-001117-42Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of doripenem in ventilator-associated pneumonia (VAP) and Intra-abdominal infection (IAI) (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Safety and tolerability of doripenem versus imipenem. Started Aug 2007; status: completed.
02
Drugs
doripenem
03
Conditions
ventilator-associated pneumonia (VAP)Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2007-001117-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001117-42.